AzTrials
AzTrials

HealthyNCT07491705

Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance

A study testing Camel Milk and Cow Milk in people with Healthy, run by United Arab Emirates University at 1 site in United Arab Emirates.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study title Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance Investigator Dr. Mo'ath Bataineh Department of Nutrition and Health College of Medicine \& Health Sciences United Arab Emirates University Brief Summary This study aims to examine the effects of post-exercise… Read more about this study

Who is it for?
Ages 18 to 39 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Camel Milk and Cow Milk
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteUnited Arab Emirates
Study dates
30 Apr 2024to 1 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Recreational athlete
  • Active 5 Days a Week
  • Male
  • Healthy
  • Non-Obese
  • 18 to 30 years old
  • No allergies to milk.

Who cannot join

  • Sedentary
  • Female
  • Allergies to milk
  • Presence of diseases

Trial locations and contacts

1 site in 1 country.

United Arab Emirates1 site
  • United Arab Emirates University Building E3 Room 0015

    Al Ain City, Abu Dhabi Emirate, 15551

Other trials in United Arab Emirates

About this study

Study title Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance

Investigator Dr. Mo'ath Bataineh Department of Nutrition and Health College of Medicine \& Health Sciences United Arab Emirates University Brief Summary This study aims to examine the effects of post-exercise camel milk consumption on recovery and subsequent high-intensity cycling performance in recreationally trained adult males. The primary objective is to determine whether camel milk improves time to exhaustion and overall workload compared with cow's milk or water. Secondary objectives include assessing its impact on muscle soreness, muscle damage, and inflammatory markers following intense exercise.

Read more

Participants are healthy, non-obese males over 18 years of age with no milk allergies and not using antioxidant supplements, anti-inflammatory drugs, or antibiotics. A total of 12 individuals will be enrolled.

The study involves four laboratory visits. The first includes an educational workshop on recording diet and exercise, development of an individualized standardized diet, and baseline assessments of body measurements and aerobic performance (peak work rate, heart rate, maximum speed at exhaustion, and VO₂max). The remaining three visits occur 4-5 days apart. In each session, resting physiological measures are recorded, followed by a cycling exercise. Participants then consume the assigned experimental beverage and rest for 210 minutes before completing a second cycling test. Four blood samples are collected per visit at designated time points.

Participation is voluntary, and individuals may withdraw at any time. There are no anticipated risks beyond potential discomfort from some questions or procedures. Although participants may not receive direct personal benefit, the findings may contribute to improved understanding of exercise recovery strategies.

All collected information will remain confidential, with identifying data stored securely and not included in any publications. Study results will be disseminated through peer-reviewed journals, conferences, and required reports to UAEU's Human Research Ethics Committee and the Research Office. The project is conducted and funded by United Arab Emirates University and has received ethical approval by UAEU Human Ethics Committee on February 7, 2024, (ERH_2023_3935).

Read the detailed description

Study title Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance

Investigator Dr. Mo'ath Bataineh Department of Nutrition and Health College of Medicine \& Health Sciences United Arab Emirates University Detailed Description of the Study and Procedures

  1. Study Overview The research project, titled "Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance," examines the physiological effects of post exercise camel milk consumption on high intensity cycling performance in recreationally trained adult males. The study was issued and approved on March 6, 2024, by the UAEU Human Research Ethics Committee. The investigation is conducted by Dr. Mo'ath Bataineh, Amjad Jarrar, and Zein Najjar from the Nutrition and Health Department, College of Medicine \& Health Sciences, United Arab Emirates University.
  2. Purpose of the Study The primary objective is to determine whether consuming camel milk after strenuous exercise improves subsequent high intensity cycling performance. The secondary objectives include assessing the effects of camel milk on:
  • Muscle damage
  • Muscle soreness
  • Inflammatory markers (IL 6, TNF α, IL 10)
  • Time to exhaustion and workload capacity The central hypothesis is that camel milk consumption during recovery will:
  • Enhance time to exhaustion and workload, and
  • Attenuate increases in pro inflammatory markers, more effectively than cow's milk or water.
  1. Participant Eligibility Participants are selected based on the following criteria:
  • Male, non obese, over 18 years old
  • No milk allergy
  • Not consuming antioxidant or anti inflammatory supplements
  • Not taking anti inflammatory drugs or antibiotics A total of 12 participants are enrolled.
  1. Participant Rights and Voluntary Participation Participation is strictly voluntary. Individuals may withdraw at any time without providing a reason. A participant information sheet and consent form are provided.
  2. Study Procedures 5.1 Number of Visits

Participants complete four laboratory visits:

Visit 1 - Training \& Baseline Measurements

  • Educational workshop on accurate food and exercise logging
  • Design of individualized standardized diet including 2 daily servings of dairy
  • Measurements collected:
  • Height and weight
  • Peak work rate
  • Heart rate
  • Maximum speed at exhaustion
  • VO₂MAX Visits 2-4 - Testing Days

Visits occur 4-5 days apart. Each visit includes:

  1. Baseline measurements: resting heart rate, blood pressure, oxygen consumption, and CO₂ production
  2. First cycling exercise on a bicycle ergometer
  3. Recovery period:
  • Immediate consumption of the assigned recovery beverage (camel milk, cow's milk, or water)
  • 210 minute rest period
  1. Second cycling exercise
  2. Blood sampling at four time points: pre exercise, mid exercise, end of exercise, and during recovery
  3. Measurement Protocols 6.1 Anthropometric Measurements
  • Height: Measured on a digital column scale following standardized positioning guidelines.
  • Body Composition: Measured using the InBody 720. Participants refrain from food/drink for 3 hours and empty bladder 30 minutes before testing. 6.2 Exercise Performance Testing
  • Peak Power Output (PPO): Assessed using a cycle ergometer with warming-up procedures and gradual resistance increase.
  • Heart Rate: Measured using the Polar H10 sensor.
  • VO₂MAX: Determined using a calibrated metabolic cart (21-23 °C; reference gases 16% O₂, 3.99% CO₂).
  1. Biological Sampling and Laboratory Analyses 7.1 Blood Sampling Performed by a licensed technician. Steps include vein identification, sterile needle insertion, sample labeling, and proper storage at 4-8 °C for ≤24 hours. 7.2 Plasma Collection Blood is centrifuged at 3200-3500 rpm for 10-15 minutes. Plasma is stored at -80 °C. 7.3 Hemoglobin \& Hematocrit Measured using HemoCue following standardized finger prick and cuvette handling procedures. 7.4 Creatine Kinase (CK) Assayed using the cobas c111 analyzer with reagent loading, calibration, QC checks, and automated calculation. 7.5 Cytokines
  • IL 6: Measured using cobas e411 with reagent preparation, calibration, and QC.
  • TNF α and IL 10: Assessed using ELISA with standard preparation, incubation, washing, TMB development, and absorbance reading at 450 nm.
  1. Risks and Benefits There are no physical risks expected from participation. Participants may skip any question they find uncomfortable. While there may be no direct benefits, the study contributes to improved understanding of exercise recovery strategies.
  2. Confidentiality All collected data remain strictly confidential:
  • No names are recorded on forms.
  • Data are accessible only to the research team.
  • Electronic files are stored on password protected devices.
  • Consent forms are stored securely in the PI's office.
  • Publications and reports use group-level anonymized data only.
  1. Dissemination of Results Results will be:
  • Published in international peer reviewed journals
  • Presented at scientific conferences
  • Reported to the UAEU Human Research Ethics Committee and UAEU Research Office No individually identifiable data will be shared.
  1. Funding and Oversight The study is organized by United Arab Emirates University and funded by the UAEU Research Office. Ethical oversight is provided by the UAEU Human Research Ethics Committee on February 7, 2024, (ERH_2023_3935).
Conditions
Healthy
Being tested
Control, Camel Milk, Cow Milk
Keywords
Milk, Exercise, Recovery, Induced Inflammation, Physical Performance
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ControlOther

    Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).

  • Camel MilkDietary supplement

    Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).

  • Cow MilkDietary supplement

    Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).

Study groups in NCT07491705
Study groupRoleWhat they receive
ControlOtherNo treatment
Receives: Other: Control
Camel MilkExperimentalReceived camel milk
Receives: Dietary Supplement: Camel Milk
Cow MilkExperimentalReceived cow milk
Receives: Dietary Supplement: Cow Milk

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to Exhaustion (minutes)

    Duration of the cycling-to-exhaustion test recorded in minutes

    Measured: From enrollment to the end of treatment at 6 hours

  2. Exercise Capacity (workload in watts)

    Maximum workload achieved during the post recovery exercise capacity test

    Measured: From enrollment to the end of treatment at 6 hours

Secondary outcomes (6)
  1. Heart Rate (beats per minute)

    Mean and peak HR recorded throughout exercise sessions

    Measured: From enrollment to the end of treatment at 6 hours

  2. Rating of Perceived Exertion (RPE units)

    RPE assessed using the Borg scale during exercise

    Measured: From enrollment to the end of treatment at 6 hours

  3. Oxygen Consumption (VO₂; mL·kg-¹·min-¹)

    VO₂ continuously measured during exercise

    Measured: From enrollment to the end of treatment at 6 hours

  4. Carbon Dioxide Production (VCO₂; mL·kg-¹·min-¹)

    VCO₂ continuously measured during exercise

    Measured: From enrollment to the end of treatment at 6 hours

  5. Plasma Cytokines (pg/mL)

    • Interleukin 6 (IL6)
    • Interleukin 10 (IL10)
    • Tumor necrosis factor α (TNF α) Each cytokine will be reported separately due to having distinct units

    Measured: From enrollment to the end of treatment at 6 hours

  6. Creatine Kinase (U/L)

    Serum CK measured pre and post exercise

    Measured: From enrollment to the end of treatment at 6 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2026
  2. Study start30 Apr 2024
  3. Primary completion30 May 2025
  4. Study completion1 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07491705
Sponsor's protocol ID
ERH_2023_3935
Status last verified
Mar 2026
First submitted
11 Mar 2026
Last updated
24 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: To maintain the privacy of the individuals

Questions about this trial

What is this clinical trial studying?

A study testing Camel Milk and Cow Milk in people with Healthy, run by United Arab Emirates University at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to Exhaustion (minutes) (time frame: From enrollment to the end of treatment at 6 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in